42^nd World Cancer Conference

Cancer Diagnostic Market

The Cancer Diagnostics Market involves various aspects of treatment. It is segmented on the basis Technology, Application & Region.

Based on Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy),   the cancer diagnostics market is categorized into platform-based and instrument-basedBased on the application, the cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, and others. On the basis of region, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia.